Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Recently, FVU has garnered research interest as a critical component in cancer diagnostic test development, particularly in the liquid biopsy field.

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.

Liquid biopsy refers to the analysis of bodily fluids, most commonly blood, to detect tumor-derived analytes such as circulating tumor cells (CTCs) or ctDNA. The detection of ctDNA has shown great ...

Crucially, exosomes provide a protective environment for the various analytes contained in them ... custom molecular solutions for their liquid biopsy needs, including clinical research services ...

PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...